|
USA-WI-HUMBLE Azienda Directories
|
Azienda News:
- 11 new research advances from the past year - MD Anderson Cancer Center
Over the past year, MD Anderson researchers and clinicians have investigated the gut microbiome, examined the earliest genesis of lung adenocarcinoma cells, tested new and improved therapies, and more Their breakthroughs in cancer research continue to drive forward our mission to end cancer
- One Year in Cancer Research and Much to Celebrate
NCI Director Dr Kimryn Rathmell reviews some of the most noteworthy cancer research findings from 2024, including advances in immunotherapy for children with cancer, a potential therapy for cachexia, and valuable insights into cancer biology
- Transforming the landscape of cancer treatment with seven promising . . .
Despite decades of research and advancements in cancer therapy, conventional treatment modalities—surgery, chemotherapy, and radiotherapy—remain essential as the cornerstone for cancer management However, their efficacy is often limited, particularly in patients with advanced metastatic disease As a result, there exists a substantial
- AACR Cancer Progress Report Details Exciting Advances in Cancer . . .
In addition to providing the latest statistics on cancer incidence, mortality, and survivorship, the AACR Cancer Progress Report 2023 offers detailed updates and important context regarding the latest research in cancer etiology, early detection, diagnosis, treatment, prevention, and survivorship
- AACR 2025 - Nature Reviews Cancer
The 2025 American Association for Cancer Research (AACR) annual meeting was held in Chicago, Illinois, bringing together approximately 21,500 participants from 81 countries under the theme
- Johnson Johnson showcases latest advancements in cancer innovation . . .
Johnson Johnson showcases latest advancements in cancer innovation with more than 70 clinical and real-world studies at ASCO and EHA; Oncology Advancing research in benign hematologic conditions, three poster presentations on warm autoimmune hemolytic anemia (wAIHA) highlight critical findings on the disease prevalence, treatment
- Reflections on Advances in Cancer Research in 2024
There have been many impactful advances in basic, translational, and clinical cancer research in 2024
- ASCO 2025: Big Advancements Across the Board - Susan G. Komen®
Big advancements were announced across the board at the 2025 American Society of Clinical Oncology (ASCO) meeting Phase 3 randomized clinical trials test how well a new therapy compares to the current standard of care, and results from these studies have the potential to change how breast cancer is treated There were five presentations of new phase 3 clinical trial results for breast cancer
- Mayo Clinic experts present key cancer research findings at ASCO
The event, recognized as one of the largest gatherings in the field of cancer research, will feature 59 Mayo Clinic-authored abstracts highlighting advancements in cancer care Among the standout presentations are practice-changing studies focused on chemotherapy approaches, artificial intelligence (AI) applications in oncology, cancer care at
- Innovation and Discovery: A 30-Year Journey in Advancing Cancer Care
Innovations such as clustered regularly interspaced short palindromic repeats (CRISPR) gene editing, artificial intelligence, tele-health, cryo-electron microscopy, and robotic surgery have revolutionized our approaches to cancer research, diagnosis, and treatment
|
|